Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)

Detalles Bibliográficos
Autores principales: Scherbak, Nikolai N., Kruse, Robert, Nyström, Thomas, Jendle, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695721/
http://dx.doi.org/10.4093/dmj.2023.0355
_version_ 1785153624152735744
author Scherbak, Nikolai N.
Kruse, Robert
Nyström, Thomas
Jendle, Johan
author_facet Scherbak, Nikolai N.
Kruse, Robert
Nyström, Thomas
Jendle, Johan
author_sort Scherbak, Nikolai N.
collection PubMed
description
format Online
Article
Text
id pubmed-10695721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-106957212023-12-05 Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) Scherbak, Nikolai N. Kruse, Robert Nyström, Thomas Jendle, Johan Diabetes Metab J Response Korean Diabetes Association 2023-11 2023-11-24 /pmc/articles/PMC10695721/ http://dx.doi.org/10.4093/dmj.2023.0355 Text en Copyright © 2023 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Response
Scherbak, Nikolai N.
Kruse, Robert
Nyström, Thomas
Jendle, Johan
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title_full Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title_fullStr Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title_full_unstemmed Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title_short Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
title_sort glimepiride compared to liraglutide increases plasma levels of mir-206, mir-182-5p, and mir-766-3p in type 2 diabetes mellitus: a randomized controlled trial (diabetes metab j 2023;47:668-81)
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695721/
http://dx.doi.org/10.4093/dmj.2023.0355
work_keys_str_mv AT scherbaknikolain glimepiridecomparedtoliraglutideincreasesplasmalevelsofmir206mir1825pandmir7663pintype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20234766881
AT kruserobert glimepiridecomparedtoliraglutideincreasesplasmalevelsofmir206mir1825pandmir7663pintype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20234766881
AT nystromthomas glimepiridecomparedtoliraglutideincreasesplasmalevelsofmir206mir1825pandmir7663pintype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20234766881
AT jendlejohan glimepiridecomparedtoliraglutideincreasesplasmalevelsofmir206mir1825pandmir7663pintype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20234766881

Ejemplares similares